BioMedGPT-R1 - A multimodal biomedical large-scale model jointly developed by Tsinghua University and Shuimu Molecular.

What is BioMedGPT-R1?

BioMedGPT-R1 is an upgraded version of a multimodal open-source biomedical model jointly developed by the Institute for AI Industry at Tsinghua University (AIR) and Beijing Tsinghua Molecular Biotechnology Co., Ltd. Based on DeepSeek R1 technology, BioMedGPT-R1 updates the text-based model and cross-modal feature alignment, achieving a unified fusion of biological modalities (such as molecules and proteins) and natural language. The model can handle various biomedical tasks, supports cross-modal question answering and deep reasoning, and is widely used in drug molecule understanding, target discovery, and other fields. Compared to its predecessor, BioMedGPT-R1 shows significant performance improvements in tasks such as chemical molecule description and approaches human expert levels in biomedical text question answering tasks.

Main functions of BioMedGPT-R1

• Cross-modal question answering and reasoningIt supports interactive question answering using natural language and biological modalities (such as chemical molecules and proteins), and combines text and biological data for deep reasoning, providing comprehensive analysis for biomedical research.
• Drug Molecular Understanding and Analysis: To conduct reasoning and analysis on small chemical molecules in terms of structure, functional groups, and biochemical properties.
• Drug target exploration and discoveryAnalyzing biological data and textual information can help identify potential drug targets and accelerate the early stages of drug development.

Technical Principles of BioMedGPT-R1

• Multimodal fusion architectureThis approach integrates data from natural language modalities and biological modalities (such as molecules and proteins). Features are extracted based on biological modal encoders (such as molecular encoders and protein encoders), and the "aligned translation layer" is mapped to the natural language representation space, achieving unified fusion of multimodal data.
• Cross-modal feature alignmentThe model uses an alignment translation layer (Translator) to align the encoded output of the biological modality with the semantic representation of the text modality. The model processes both biological data and natural language instructions simultaneously, supporting cross-modal reasoning.
• DeepSeek R1 Distillation TechnologyThe text pedestal model is updated based on a distilled version of DeepSeek R1, improving the model's text reasoning ability and further optimizing the performance of multimodal tasks.
• Two-stage training strategy:
  • Phase 1Only the aligned translation layer is trained to map biological modality representations to the semantic space.
  • Phase TwoSimultaneously fine-tuning the alignment translation layer and the base large language model stimulates the model's multimodal deep reasoning capabilities in downstream tasks.

BioMedGPT-R1 project address

• HuggingFace model library:https://huggingface.co/PharMolix/BioMedGPT-R1

Application scenarios of BioMedGPT-R1

• Drug molecular design and optimization: Analyze molecular properties to assist in the design and optimization of drug molecules.
• Drug target discoveryBy combining biological data and literature, we can identify potential drug targets.
• Preclinical researchAnalyzing biomarkers supports disease diagnosis and drug efficacy evaluation.
• Medical text analysis: To assist in medical education, literature interpretation, and clinical decision support.